CD8A and hereditary clear cell renal cell carcinoma: To investigate whether the prognostic role of EZH2 might be driven by a modified immune response, a cohort of 1809 renal cell carcinomas was analyzed in a tissue microarray format (TMA) for EZH2 protein expression and CD8+ lymphocytes were quantitated by automated digital imaging.